James T. Corcoran
Areas of Practice
James primarily focuses his practice on patent prosecution and counseling, particularly in the areas of chemistry, pharmaceuticals and biotechnology. James has extensive experience drafting patent applications and managing patent applications and portfolios in the United States and in foreign countries. James also has experience performing prior art searches, preparing freedom to operate reviews, prosecuting reissue applications and prosecuting supplemental protection certificates. James has worked with a variety of different clients including individuals, corporations, start-up ventures, and university research centers.
Columbia Law School, J.D., 2012
Syracuse University, M.S., Chemistry, 2010
Binghamton University, B.S., Chemistry, 2007
United States Patent & Trademark Office
Teva Pharmaceutical’s U.S. and foreign patents for its Pridopidine® drug for Huntington’s Disease for which clinical studies are being, or have been, conducted.
Kennedy Institute of Rheumatology’s U.S. and foreign patent for combination therapy involving methotrexate and anti-TNF antibodies (Centocor’s Remicade® and Abbott’s Humira®) or soluble TNF receptor (Amgen/Wyeth’s Embrel®).
Corcoran, J.T.; Carberry, P.; Viernes, D.R., Chisholm, J.D. “Intramolecular Diels-Alder Reactions Utilizing Aldehyde and Ketone Dienophiles. A Rare Variant of the Diels-Alder
Reaction.” Mini-Rev. Org. Chem., 2015, 2, 149-161. DOI: 10.2174/1570193X11666141029000030